Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2025)

CapsoVision (CV) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $18.2 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 8.1% to $18.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $18.2 million for FY2025, 8.1% up from the prior year.
  • Liabilities and Shareholders Equity hit $18.2 million in Q4 2025 for CapsoVision, down from $25.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $25.7 million in Q3 2025 to a low of $9.5 million in Q2 2025.